Patents by Inventor Kyung Chul Cho

Kyung Chul Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives
    Patent number: 8518978
    Abstract: There is provided a pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives. The pharmaceutical composition includes a therapeutic effective amount of isoxazole derivatives represented by Formula 1 or pharmaceutically available salts thereof. The pharmaceutical composition may be useful to prevent and treat vascular restenosis since the pharmaceutical composition shows an anti-restenosis activity and accelerates the re-endothelization.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: August 27, 2013
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Sun Gwan Hwang, Sang Rak Choi, Jeong Woo Cho, Sung Jin Bae, Tae Sung Koo, So Young Lee, Kyung Chul Cho, Hyeon Cheol Gwon
  • Isoxazole derivatives and use thereof
    Patent number: 7915297
    Abstract: Disclosed herein are isoxazole derivatives and uses thereof. Serving as agonists of Wnt, the isoxazole derivatives activate Wnt/?-catenin signaling and thus can be used in the treatment and prevention of diseases related to the signal transduction. Also, pharmaceutically acceptable salts of the isoxazole derivatives are disclosed.
    Type: Grant
    Filed: December 28, 2006
    Date of Patent: March 29, 2011
    Assignee: SK Holdings Co., Ltd.
    Inventors: Jeong Woo Cho, Sang Rak Choi, Sun Gwan Hwang, Kyung Chul Cho, Sung Jin Bae, Tae Sung Koo
  • Pharmaceutical Composition For Preventintion And Treatment Of Restenosis Comprising Isoxazole Derivatives
    Publication number: 20110028506
    Abstract: There is provided a pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives. The pharmaceutical composition includes a therapeutic effective amount of isoxazole derivatives represented by Formula 1 or pharmaceutically available salts thereof. The pharmaceutical composition may be useful to prevent and treat vascular restenosis since the pharmaceutical composition shows an anti-restenosis activity and accelerates the re-endothelization.
    Type: Application
    Filed: June 30, 2008
    Publication date: February 3, 2011
    Inventors: Sun Gwan Hwang, Sang Rak Choi, Jeong Woo Cho, Sung Jin Bae, Tae Sung Koo, So Young Lee, Kyung Chul Cho, Hyeon Cheol Gwon
  • Isoxazole Derivatives and Use Thereof
    Publication number: 20090131336
    Abstract: Disclosed herein are isoxazole derivaties and uses thereof. Serving as agonists of Wnt, the isoxazole derivatives activate Wnt/?-catenin signaling and thus can be used in the treatment and prevention of diseases related to the signal transduction. Also, pharmaceutically acceptable salts of the isoxazole derivatives are disclosed.
    Type: Application
    Filed: December 28, 2006
    Publication date: May 21, 2009
    Inventors: Jeong Woo Cho, Sang Rak Choi, Sun Gwan Hwang, Kyung Chul Cho, Sung Jin Bae, Tae Sung Koo